The Europe Pain Management Devices Market is expected to witness market growth of 8.1% CAGR during the forecast period (2020-2026).
The key products used to treat various degrees of pain are electrical stimulators, radiofrequency ablation (RFA), analgesic infusion, and neuromodulation & neurostimulation devices. The market, in 2019 was led by the segment of neuromodulation & neurostimulation devices, which includes spinal cord stimulators (SCS), deep brain stimulators (DBS), and sacral neurostimulators.
These devices have wide-ranging uses in chronic pain management, including spinal cord stimulation, deep brain, sacral nerve, vagus nerve, Gastric Electrical Stimulation (GES), Repetitive Transcranial Magnetic Stimulation (rTMS), and electric respiratory stimulation. Neurostimulation devices are more efficient than traditional methods because they show sustained pain reduction. Additionally, traditional therapy requires the intake of medicinal products which may have many adverse effects. Those factors are expected to contribute to this segment 's growth.
Radiofrequency ablation devices played a major role in the treatment of cancer pain. These devices exert action through high-temperature thermal therapy, which by heating tissue to 100°C induces the coagulation of necrotic cells. This RFA equipment mechanism helps kill cancer cells and thus enables effective pain management.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Study
Market Segmentation:
By Product
By Application
By Country
Companies Profiled
Unique Offerings from the Publisher
The key products used to treat various degrees of pain are electrical stimulators, radiofrequency ablation (RFA), analgesic infusion, and neuromodulation & neurostimulation devices. The market, in 2019 was led by the segment of neuromodulation & neurostimulation devices, which includes spinal cord stimulators (SCS), deep brain stimulators (DBS), and sacral neurostimulators.
These devices have wide-ranging uses in chronic pain management, including spinal cord stimulation, deep brain, sacral nerve, vagus nerve, Gastric Electrical Stimulation (GES), Repetitive Transcranial Magnetic Stimulation (rTMS), and electric respiratory stimulation. Neurostimulation devices are more efficient than traditional methods because they show sustained pain reduction. Additionally, traditional therapy requires the intake of medicinal products which may have many adverse effects. Those factors are expected to contribute to this segment 's growth.
Radiofrequency ablation devices played a major role in the treatment of cancer pain. These devices exert action through high-temperature thermal therapy, which by heating tissue to 100°C induces the coagulation of necrotic cells. This RFA equipment mechanism helps kill cancer cells and thus enables effective pain management.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Study
Market Segmentation:
By Product
- Neuromodulation & Neurostimulation Devices
- Analgesic Infusion Pumps and
- Ablation Devices
By Application
- Neuropathic Pain
- Musculoskeletal Pain
- Cancer Pain
- Facial & Migraine Pain and
- Other Applications
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- Kimberly-Clark Corporation
- Stryker Corporation
- Colfax Corporation (DJO Global, Inc.)
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Europe Pain Management Devices Market by Product
Chapter 5. Europe Pain Management Devices Market by Application
Chapter 6. Europe Pain Management Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- Kimberly-Clark Corporation
- Stryker Corporation
- Colfax Corporation (DJO Global, Inc.)
Methodology
LOADING...
